Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ENZC Enzolytics Inc (PK)

0.00055 (2.2%)
Nov 30 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,800,696
Bid Price 0.025
Ask Price 0.026
News -
Day High 0.0259


52 Week Range


Day Low 0.0245
Company Name Stock Ticker Symbol Market Type
Enzolytics Inc (PK) ENZC OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00055 2.2% 0.0255 16:00:26
Open Price Low Price High Price Close Price Prev Close
0.0247 0.0245 0.0259 0.0255 0.02495
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
123 1,800,696 $ 0.025097 $ 45,192 - 0.016 - 0.132
Last Trade Time Type Quantity Stock Price Currency
15:56:46 15,000 $ 0.0255 USD

Enzolytics Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
92.51M 3.01B -1.98B 0 -2.94M -0.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Enzolytics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ENZC Message Board. Create One! See More Posts on ENZC Message Board See More Message Board Posts

Historical ENZC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.02240.0260.0210.02454334,920,3900.003113.84%
1 Month0.02970.030.0160.02303517,815,815-0.0042-14.14%
3 Months0.041940.060250.0160.0333056,930,113-0.01644-39.2%
6 Months0.05370.060250.0160.03973897,241,554-0.0282-52.51%
1 Year0.04490.1320.0160.05287027,888,638-0.0194-43.21%
3 Years0.07950.9580.0160.161035916,530,968-0.054-67.92%
5 Years0.00250.9580.00010.070280227,135,9320.023920.0%

Enzolytics (PK) Description

Business Description Enzolytics, Inc. (the "Company" or "ENZC") is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The Company is committed to creating drugs for the better health of mankind. ENZC's flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from major neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective.

Your Recent History

Delayed Upgrade Clock